vs
CAMDEN NATIONAL CORP（CAC）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
PROCEPT BioRobotics Corp的季度营收约是CAMDEN NATIONAL CORP的1.3倍（$83.1M vs $64.3M），CAMDEN NATIONAL CORP净利率更高（34.0% vs -38.1%，领先72.1%），过去两年PROCEPT BioRobotics Corp的营收复合增速更高（24.8% vs 22.6%）
卡姆登国民银行是一家总部位于美国缅因州卡姆登的商业银行，是上市银行控股公司卡姆登国民集团的核心子公司。该行创立于1875年，1984年完成企业重组后成为控股公司直接持有的全资子公司。2025年与诺斯韦金融合并后，合并后机构总资产约为70亿美元。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
CAC vs PRCT — 直观对比
营收规模更大
PRCT
是对方的1.3倍
$64.3M
净利率更高
CAC
高出72.1%
-38.1%
两年增速更快
PRCT
近两年复合增速
22.6%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $64.3M | $83.1M |
| 净利润 | $21.9M | $-31.6M |
| 毛利率 | — | 64.9% |
| 营业利润率 | — | -4.1% |
| 净利率 | 34.0% | -38.1% |
| 营收同比 | — | 20.2% |
| 净利润同比 | — | -27.9% |
| 每股收益（稀释后） | $1.29 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CACPRCT
| Q1 26 | $64.3M | $83.1M | ||
| Q4 25 | $68.1M | $76.4M | ||
| Q3 25 | $65.4M | $83.3M | ||
| Q2 25 | $62.3M | $79.2M | ||
| Q1 25 | $60.1M | $69.2M | ||
| Q4 24 | $47.6M | $68.2M | ||
| Q3 24 | $45.0M | $58.4M | ||
| Q2 24 | $42.8M | $53.4M |
净利润CACPRCT
| Q1 26 | $21.9M | $-31.6M | ||
| Q4 25 | $22.6M | $-29.8M | ||
| Q3 25 | $21.2M | $-21.4M | ||
| Q2 25 | $14.1M | $-19.6M | ||
| Q1 25 | $7.3M | $-24.7M | ||
| Q4 24 | $14.7M | $-18.9M | ||
| Q3 24 | $13.1M | $-21.0M | ||
| Q2 24 | $12.0M | $-25.6M |
毛利率CACPRCT
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
营业利润率CACPRCT
| Q1 26 | — | -4.1% | ||
| Q4 25 | 41.5% | -40.6% | ||
| Q3 25 | 40.5% | -27.8% | ||
| Q2 25 | 28.5% | -28.0% | ||
| Q1 25 | 10.3% | -39.7% | ||
| Q4 24 | 38.7% | -28.9% | ||
| Q3 24 | 35.2% | -38.4% | ||
| Q2 24 | 34.7% | -50.3% |
净利率CACPRCT
| Q1 26 | 34.0% | -38.1% | ||
| Q4 25 | 33.1% | -39.1% | ||
| Q3 25 | 32.4% | -25.7% | ||
| Q2 25 | 22.6% | -24.7% | ||
| Q1 25 | 12.2% | -35.8% | ||
| Q4 24 | 30.8% | -27.6% | ||
| Q3 24 | 29.1% | -35.9% | ||
| Q2 24 | 28.0% | -48.0% |
每股收益（稀释后）CACPRCT
| Q1 26 | $1.29 | $-0.56 | ||
| Q4 25 | $1.33 | $-0.54 | ||
| Q3 25 | $1.25 | $-0.38 | ||
| Q2 25 | $0.83 | $-0.35 | ||
| Q1 25 | $0.43 | $-0.45 | ||
| Q4 24 | $1.00 | $-0.34 | ||
| Q3 24 | $0.90 | $-0.40 | ||
| Q2 24 | $0.81 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $245.6M |
| 总债务越低越好 | $514.4M | $51.7M |
| 股东权益账面价值 | $710.0M | $347.7M |
| 总资产 | $7.0B | $487.1M |
| 负债/权益比越低杠杆越低 | 0.72× | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资CACPRCT
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
总债务CACPRCT
| Q1 26 | $514.4M | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
股东权益CACPRCT
| Q1 26 | $710.0M | $347.7M | ||
| Q4 25 | $696.6M | $365.9M | ||
| Q3 25 | $676.4M | $380.3M | ||
| Q2 25 | $652.1M | $385.8M | ||
| Q1 25 | $640.1M | $389.2M | ||
| Q4 24 | $531.2M | $402.2M | ||
| Q3 24 | $529.9M | $241.2M | ||
| Q2 24 | $508.3M | $251.8M |
总资产CACPRCT
| Q1 26 | $7.0B | $487.1M | ||
| Q4 25 | $7.0B | $508.1M | ||
| Q3 25 | $7.0B | $511.5M | ||
| Q2 25 | $6.9B | $513.1M | ||
| Q1 25 | $7.0B | $519.4M | ||
| Q4 24 | $5.8B | $534.0M | ||
| Q3 24 | $5.7B | $374.1M | ||
| Q2 24 | $5.7B | $374.4M |
负债/权益比CACPRCT
| Q1 26 | 0.72× | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
